Dipeptidyl Peptidase-4 inhibitor, Vildagliptin, improves trabecular bone mineral density and microstructure in obese, insulin-resistant, pre-diabetic rats
Margulies K.B., Hernandez A.F., Redfield M.M., et al
Chc Ch v gia nh lun di do sc khe
Average Weight Loss on Semaglutide In the main clinical trial that supported semaglutide's approval for weight management (the STEP 1 trial), adults who took the 2.4 mg weekly dose lost, on average, about 15% of their body weight over 68 weeks, compared with a much smaller amount in the placebo group
The bad news is that we still havent reached a consensus on how much protein is enough (youd think wed have solved this by 2025)